Clinical Pharmacokinetics of Vemurafenib in BRAF-Mutated Melanoma Patients

C. M. Nijenhuis; A. D.R. Huitema; C. Blank; J. B.A.G. Haanen; J. V. van Thienen; H. Rosing; J. H.M. Schellens; J. H. Beijnen

doi:10.1002/jcph.788

Clinical Pharmacokinetics of Vemurafenib in BRAF-Mutated Melanoma Patients

C. M. Nijenhuis^*
, A. D.R. Huitema
, C. Blank
, J. B.A.G. Haanen
, J. V. van Thienen
, H. Rosing
, J. H.M. Schellens
, J. H. Beijnen

^*Corresponding author for this work

Research output: Contribution to journal › Article › Academic › peer-review

4 Citations (Scopus)

Original language	English
Pages (from-to)	125-128
Number of pages	4
Journal	Journal of Clinical Pharmacology
Volume	57
Issue number	1
DOIs	https://doi.org/10.1002/jcph.788
Publication status	Published - 1 Jan 2017
Externally published	Yes

Keywords

exposure-response
LC-MS/MS
pharmacokinetics
routine clinical care
therapeutic drug monitoring
vemurafenib

Access to Document

10.1002/jcph.788

Cite this

@article{3d0d6a864d3f40fe844e8a50f80d8bb0,

title = "Clinical Pharmacokinetics of Vemurafenib in BRAF-Mutated Melanoma Patients",

keywords = "exposure-response, LC-MS/MS, pharmacokinetics, routine clinical care, therapeutic drug monitoring, vemurafenib",

author = "Nijenhuis, \{C. M.\} and Huitema, \{A. D.R.\} and C. Blank and Haanen, \{J. B.A.G.\} and \{van Thienen\}, \{J. V.\} and H. Rosing and Schellens, \{J. H.M.\} and Beijnen, \{J. H.\}",

year = "2017",

month = jan,

day = "1",

doi = "10.1002/jcph.788",

language = "English",

volume = "57",

pages = "125--128",

journal = "Journal of Clinical Pharmacology",

issn = "0091-2700",

publisher = "Wiley-Blackwell",

number = "1",

}

TY - JOUR

T1 - Clinical Pharmacokinetics of Vemurafenib in BRAF-Mutated Melanoma Patients

AU - Nijenhuis, C. M.

AU - Huitema, A. D.R.

AU - Blank, C.

AU - Haanen, J. B.A.G.

AU - van Thienen, J. V.

AU - Rosing, H.

AU - Schellens, J. H.M.

AU - Beijnen, J. H.

PY - 2017/1/1

Y1 - 2017/1/1

KW - exposure-response

KW - LC-MS/MS

KW - pharmacokinetics

KW - routine clinical care

KW - therapeutic drug monitoring

KW - vemurafenib

UR - https://www.scopus.com/pages/publications/84994399670

U2 - 10.1002/jcph.788

DO - 10.1002/jcph.788

M3 - Article

C2 - 27365214

AN - SCOPUS:84994399670

SN - 0091-2700

VL - 57

SP - 125

EP - 128

JO - Journal of Clinical Pharmacology

JF - Journal of Clinical Pharmacology

IS - 1

ER -

Clinical Pharmacokinetics of Vemurafenib in BRAF-Mutated Melanoma Patients

Keywords

Access to Document

Other files and links

Cite this